JPMorgan raises target for Aflac stock to USD 119.00

Published on 10/19/2026 at 09:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aflac stock costs EUR 107.30 on October 19, 2026 at Lang & Schwarz. Results are due November 4 and fiscal 2027 EPS estimate rose to USD 7.65.

Analyst views and reporting dates

JPMorgan raised its Aflac target to USD 119.00 from USD 116.00 on October 15, 2026.
Dowling & Partn lifted its fiscal 2027 earnings estimate to USD 7.65 from USD 7.55 on October 13, 2026.
Aflac stock was trading at EUR 107.30 at 9:41 a.m. CEST at Lang & Schwarz on October 19, 2026.

Börsen-Editorial: NYSE-Handelssaal mit Finanzkursen auf Bildschirmen — AFLAC Inc. NYSE stock exchange trading floor editorial photograph with insurance financials charts, ISIN US0010551028, Illustration mit AI erstellt.

Aflac Incorporated (ISIN US0010551028) was trading at EUR 107.30 at Lang & Schwarz on October 19, 2026 at 9:41 a.m. CEST. Markets Insider reported on October 15, 2026 that JPMorgan raised its Aflac price target to USD 119.00 from USD 116.00 while keeping a Neutral rating. The target revision came in a third-quarter earnings preview and leaves valuation as the immediate investor question.

Three dated valuation signals

On August 6, 2026, Aflac reported earnings per share of USD 1.75 for the second quarter, below the USD 1.76 consensus, while revenue reached USD 4.22 billion against USD 4.11 billion expected, according to MarketBeat. Revenue declined 1.00 percent year over year, giving investors a mixed earnings baseline.

On October 13, 2026, Dowling & Partn raised its fiscal 2027 earnings estimate to USD 7.65 per share from USD 7.55, while the current full-year consensus stood at USD 7.04, MarketBeat reported. The revision provides a quantified counterweight to the second-quarter earnings-per-share miss.

On October 15, 2026, JPMorgan raised its target to USD 119.00 from USD 116.00 and retained a Neutral rating, according to Markets Insider. The sequence shows a narrow divide between improving longer-term estimates and cautious near-term earnings commentary.

What comes next for results?

Aflac said in its press-release archive that it will release third-quarter 2026 results on November 4, 2026 and host a CFO video update and webcast on November 5, 2026, according to Aflac. Those dates will provide the next reported test of revenue, earnings per share and the assumptions behind current analyst estimates.

Stock price and reporting calendar

Aflac operates supplemental health and life insurance businesses through its Aflac U.S. and Aflac Japan divisions. Its latest reported second-quarter revenue was USD 4.22 billion, while the next results date is November 4, 2026.

Aflac was trading at EUR 107.30 at Lang & Schwarz on October 19, 2026 at 9:41 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Aflac stock.